Danish Integrated Antimicrobial Resistance Monitoring and Research Program
Anette M. Hammerum* , Ole E. Heuer†, Hanne-Dorthe Emborg†, Line Bagger-Skjøt*, Vibeke F. Jensen†, Anne-Marie Rogues*, Robert L. Skov*, Yvonne Agersø†, Christian T. Brandt*, Anne Mette Seyfarth†, Arno Muller*, Karin Hovgaard‡, Justin Ajufo§, Flemming Bager†, Frank M. Aarestrup†, Niels Frimodt-Møller*, Henrik C. Wegener†, and Dominique L. Monnet*
Author affiliations: *Statens Serum Institut, Copenhagen, Denmark; †Technical University of Denmark, Copenhagen, Denmark; ‡Danish Medicine Agency, Copenhagen, Denmark; §Danish Veterinary and Food Administration, Søborg, Denmark;
Figure 3. Trends in glycopeptide resistance among Enterococcus faecium from broiler chickens and pigs and the consumption of the growth promoter avoparcin in animals, Denmark, 1994–2005 (revised from 12).
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.